Ascend MegaBio

Founded in 2023, and based in Nanjing, China, Ascend MegaBio operates in the biotechnology sector, concentrating on the development of enzyme preparations and bio-synthetic products. Led by a team of experienced professionals, Ascend MegaBio is committed to advancing biotechnology applications. In July 2025, Ascend MegaBio closed a series A funding from unspecified investors. Ascend MegaBio offers a range of products including enzyme preparations, bio-synthetic solutions, and health-focused functional products.

Their core innovations feature flavor management agents like NeverBitter™ and UltraSmoothy®, as well as Tang Aijian® for glycemic control, and preservative agents under the AscendPro® brand. These products cater to diverse sectors including food, agriculture, cosmetics, pharmaceuticals, and consumer goods, aiming to improve health outcomes and quality of life. Ascend MegaBio employs a B2B business model, supplying high-performance ingredients directly to manufacturers and retailers. The company has established structured partnerships for distributing its key products, particularly the Tang Aijian® series and AscendPro® line.

This approach, coupled with competitive pricing strategies, supports revenue growth by meeting market demand for innovative and sustainable solutions. The company will further expand its R&D investment, accelerate the commercialization of technological achievements, and provide the market with more efficient bio-based solutions.